Adults whose eczema fails to clear despite dermatologist recommendations may actually be managing a different condition. The American Academy of Dermatology released its first-ever guidelines specifically addressing treatment-resistant atopic dermatitis in adults, published August 31 in the Journal of the American Academy of Dermatology.
Adult-Onset Eczema Presents Unique Diagnostic Challenges
The guidelines highlight a key distinction: about 1 in 4 adult AD cases actually start in adulthood, a pattern that’s historically harder to diagnose than the childhood version most people associate with eczema. Roughly 2 percent of adults worldwide have AD, and until now there’s been no dedicated guidance on what to do when a presumed case just won’t respond.
Dr. Dawn Davis, a dermatologist from Rochester, Minnesota and senior author of the guidelines, told Medscape that persistent, treatment-resistant symptoms signal doctors to reconsider the original diagnosis rather than assume the case is simply harder to treat.
Conditions That Mimic Eczema Can Stall Treatment
The new guidelines identify several conditions that can masquerade as eczema, including allergic or irritant contact dermatitis, food allergies, asthma, allergic rhinitis, psoriasis, hives, and in rare cases, skin lymphoma. Dr. Davis noted seeing this pattern repeatedly in her practice, where patient flares do not always trace back to eczema itself.
This overlap is common in dermatology, where reactions to skincare ingredients get misattributed to eczema. The misdiagnosis problem has been building for years, but this marks the first time the AAD has provided doctors with a formal approach to address it systematically.
Read Also: Phoebe Dynevor’s dual-wedding makeup glows under candlelight
The American Academy of Dermatology recommends doctors use a decision tree based on individual case presentation rather than applying a single testing protocol across all patients.
Guidelines Recommend Targeted Testing Over Treatment Escalation
Patch testing becomes the priority for adult-onset cases, rashes in unusual locations like hands or eyelids, or dermatitis that is not improving under standard treatment. Biopsies are recommended when symptoms suggest an entirely different condition.
Skin scraping and cultures help rule out infections or infestations that can mimic eczema. When these tests do not resolve the issue, the guidelines direct doctors to refer patients to a specialist instead of automatically escalating treatment.
Dr. Peter Lio, a Chicago dermatologist not involved in writing the guidelines, described the core message as “deceptively simple”: a stalled treatment does not mean the disease is stubborn—it may mean the diagnosis needs revisiting. This mirrors recent shifts in eczema biologic dosing, where treatment is increasingly matched to individual patient profiles rather than fixed protocols.
